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OBJECTIVES: To detemine the effectiveness of an in-hospital cardiovascutar
risk menagement sb'ategy In Acute Myocardial Infarction patients and to assess
roles and responsibilities of cardiology staff for risk factor management.
METHODS: A descriptive study, based on chart reviews. compared risk factor
identification, documentation and management before and after implementation
of a risk management strategy. Perceived rofes and responsibilities of cardiology
staff were deI.mined through SlM'V8ys.
RESULTS; The strategy was partially effective. One of seven variables tor risk
identification and documentation (history of coronary artery disease) achieved
statistical Significance (p < 0.04). Four of eight management variables (lipid
measurement, statin drug utiNzation, stress counseling and~ng counseling)
achieved statistical significance (p < 0.001). Cardiology staff was in near total
agreement (98%) with the need for a team approach for in-hospital risk
management
CONCLUSIONS: Despile improvements. significant future opportunities exist.
Chart foons are being revised; a coUaborative strategy at the time of re-launch is
recommended.
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CHAPTER I
INTRODUCTION. PURPOSE & OBJECTIVES AND RATIONALE
1.0 Introduction
cardiovascular disease (eVO) is the primary cause of death, disability and iUness
in North America (1,2,15,48). Cardiovascular disease, which refers to aM
diseases of the circulatory system, consists of two major colT1Xl"ents: a)
ischemic heart disease (IHD) inducting acute myocardial infarction (AMI) and
angina and b) cerebrovascular disease, including stroke.
The significant burden of cardiovaSCliar disease impacts society in both human
and economic terms. evo is responsible for more hospital discharges than any
other disease in Canada (27). In 1996 cardiovascular disease accounted for
IT'Ore than one third (37%), of all deaths in canada with ischemic heart disease,
chiefly acute myocardial infarction, being responsible for 21% of those
cardiovascular deaths (3, 48). A recent Canadian analysis (4) estimated the total
cost of cardiovascular disease from a societal viewpoint. Direct costs induded
expenditures on hospital care, other institutions, physician services, other health
professionals, drugs and research while indtrect: costs induded the costs
associated with lost: productivity due to premature mortality or disability. The total
cost of cardiovascular disease was $18.0 billion in 1994 (the 10VI/8I' and upper
bounds were $14.1 and $20.4 billion), with direct and indirect cost components of
$10.4 and $7.6 billion respectively.
The highest age-adjusted mortality rate in Ihe counby is for cve at 226 per
100,000 population, followed by cancer mortality at 185 per 100,000. The cve
mortality rate has been declining since the mid--1960s, lik~y due in part to
decreases in smoking and dietary fat intake, increase In exercise and improved
medical/surgical management. Although the absolute number of cve deaths has
increased only modestly (from 79,115 in 1995 to 79, 447 in 1996), when one
considers the current and pro;eeted inaeasing numbers of elder1y individuals in
the population, the toll of cve remains significant (27).
The Atlantic provinces have consistently experienced higher CVD mortality rates
than the western provinces. For example, in 1996 the highest age-standardized
mortality rate for cardiovascular disease in males was in Prince Edward Island at
365 per 100,000 while Newfoundland and Labrador experienced the highest rate
in females at 225 per 100,000. Of nOle, the prevalence rates for smoking, high
blood pressure and obesity run parallel to the provincial rates for cardiovaSOJlar
disease (27). In a 1997 overview of provincial and territorial mortality indicators,
Newfoundland and Labrador had the highest standardized rate for ischemic heart
disease with 180 per 100,000 population, followed by Quebec with 141 per
100,000; the Canadian standartized mortality rate was 131 per 100,000 (27).
Due to the significant human and economic costs, to which Acute Myocardial
Infarction (AMI) contributes significandy, numerous dinical trials have focused on
the diagnosis and management of AMI over the past HYenlI decades. These
investigations began at approximately the same time as specialized coronary
care units (CCUs) were being established in the 1970's. Fortunalely, many
medical therapies have been proven to be efficacious in reducing the burden of
AMI (1). Such medical therapies consist of acute management strategies and
preventive strategies. The focus of the cunenl research is to examne one
component of preventive care, that of in·hospilal risk-factor management after
AMI.
There has been considerable progress made in tenns of the understanding of the
vascular biology of atherosderosis (5,13), the epidemiology of coronary artery
disease (CAD)(2), the efficacy of numerous interventions which reduce coronary
events (6,7.8,9) and the cost effectiveness of these interventions (10). The
evidence has been considered compelling enough to result in the joint
forrnJlation of guidelines by the American Heart. Association (AHA) and the
American College of Cardiology (ACC). These guidelines support comprehensive
risk reduction in patients with established vascular disease (11).
Patients with established coronary heart. disease (CHO) are at the highest risk for
recurrent coronary events, disability and death (5). In 1990 the risk of recurrent
cardiac events in persons with established disease was reported as being
increased by 10 fold.(14); that risk has likely been reduced due to improved
treatment strategies in the past decade. Patients with established coronary heart
disease represent an easily identifiable high-risk poputation and there are
effective strategies/lools to reduce risk. Therefore, modification and control of risk
factors induding lipid disorders (elevated levels of low denstty lipoprotein (lOl]
cholesterol [lOl-C] and low levels of high density lipoprotein [HOL) cholesterol
(HOl-Cn, hypertension, cigarette smoking. and diabetes mellitus (OM) should be
of priority in this population.
Secondary prevention refers to preventive measures for patients with established
vascular disease (5.22.82) such as the post-AMI patients examined within this
paper. These measures, or Interventions. are designed to delay or prevent
recurrent coronSfY events and cardiac death (5). In the Qlrrent health care
environment of cost-eontainment. preventive coronary care is best implemented
using interventions that have been proven (11). Anticipated outcomes of such
risk reduction indude decreased cardiovascular and total m:utalily, decreased
recurrent coronary events. decreased cardiovascular-refated hospitalizations and
improved quality of life for patients with CHO. There is considerable evidence
that modification of cardiovascular risk factors either singly or in combination. is
effective in reducing the number of clinical events in the secondary prevention of
heart disease (5,7,8.9,12). An American College of Cardiology (ACC) conference
specific to cardiovascular risk factors was held in Bethesda. Marytand in 1995.
One of the primary conclusions of this 27th Bethesda Conference on • Matching
the Intensity of Risk FlIdOr_1_tho Hazan! of Coronary [);sease
Events- (7) is that the comerstDne of optimal care is risk fador rT'IiJf'I898fT*L
The importance of risk factor management in petients with ooronaty heart
disease has been wen documented in the iteratunt (5.7.8.9.12). 1-bMtver. for
numerous potential reasons including: a) lack ofeducationlinsight of patients,
physicians. health administrators andfor govemments, b) negative attitudes
toward a perceived self-inflicted or inevitable disease. c) perceived negative
impact of lifestyle changes and d) foaJs on treatment versus prevention. the
management of cardiovascular risk factors has been a source of controversy and
actions to intervene on major risk factors have been limited (18.19).
Many potential barriers to the ~tation of 8Yidenced-based practice in
secondary prevention of CHD have been __ (9,16,17,21) some ofwhich
indude: lack of in-hospital timeJorganization for preventive care, sow uptake of
treatment guidelines by physicians. lack of bridged cotM'IJnication to primary
care famly physicians and lack of comn'JJnication to patients which leads to I"JOO-o
compliance. It may be that initiation and management of secondary prevention
have not been assigned to any particular care-giver group. resutting in no wen-
defined plan for required long term fcMlow up. One strategy or model for
management that has been described indudes a top down approach with a) the
formulation and implementation of an ," hospital- risk reduction strategy, b) the
effective corrmJf1ication of Ilat strategy to prirrery care physicians for ongoing
follow UP. c) ~ltation of a risk reduction strategy at the IewlI of the primary
care p/lysi0an and d) pationt~iance loa riskroduction slralegy (16,17).
Such an awoaeh _Is.. opportunistic risk reduction sOaIagy that
capbJres patients hospitalized with an 8\'eOl h rTlJSt be noted. however. that from
a societal ponpedive, olher models~ 10 _ tho majority of higt>risk
patients within the commJnity should be considered. More Chan one approach is
necessary to successfully impact secondary prevention of CHO.
The hospitalization period for acute coronary syndrome (ACS). including sarte
myocardial infarction (AMI), represents a unique window of opportunity for the
first step toward a risk reduction strategy. the identification of risk factors. Once
identified and doc:umented. the process of deYek>ping a tailored risk reduction
strategy is possible. 1l'is study will foaJs on the AMI hospitalization period to
gain insights into cardiovascular risk factor identification. documentation and
management Specificaly. this study will exanine the if1l)ad of an in-hospital
cardiovascular risk management strategy at the GenefaI Hospital. Health
Sciences Center (GHHSC) in St John's, Newfoundland.
1.1 Statement of the Problem
In two separate and previous reviews of AMI patients at the GHHSC (one
performod in 1998 by lhe cardoIogy nursing slafl and one poIfonnod in 1999 by
the researcher) it was evident that risk factor tdentification. documentation and
~I in INs high-risk notsatistadory. Based on finOngs
from the 1998 review. cardiology staffi~ed 8 two part risk reduction
strategy 't1otlich inducted a) a lipid proNe measurerrent wfthin the 1m 24 hours
after admission for AMI and b) utilization of three chart forms. QCalfiiDvascular
Risk Factor ProNe ilJ Risk Factor Management Plan and ilJ Cardiac Educstion
Record (appendices G,H,/).
The current study Isi~nl for several reasons. F"nl. it will 8$tablish the
current level of risk factor management at the GHHSC. Second, it will establish
whether the risk reduction strategy i~emenl8d in December 1998 has been
effective. Third. it has been established that aucit and feedback of practice
pattern behaviour relevant m the treating physician (i.e. hisItIer own data) are
interventions that are rooderately effective to change behavior (20). Although the
data within tNs rese-eh are not identified so that indMduai physicians will
receive feedback on their own practice patterns, the pi., to share the findings
with aU caniology staff could have a beneficial effect for future risk factor
management. Fourth, this stlJdy will delemine Vt'hether 8 hospital-based.
cardtology divisklnal strategy can affect change and Improve the in-hospital
identification, documentation and management of cardiovascular risk factors.
Lastly, this study will provide Information pertaining to the peroeived roles and
responsibilities of carUioIogy _ in I8mls of risk~I of post-AMI
hc>spQized patients.
12 PurJ>ose and Clbjoctivos
The purpose of this study was to review cardioVasaAar risk factor tdentification,
documentation and management in the high risk AMI population at the GHHSC
in S1. John's, Newfoundland before and after the i""P"tmentation of a cardiology
divisional "in-hospital- risk management strategy and to assess its effect.
The following objectives were examined in the study:
1) To determne whether ani~ risk management strategy was effective
in terms of increasing risk factor tdentiftcation and documentation.
2) To detemine whether an in.hospital risk management strategy was effective
in terms of increasing in-hospitaI risk factorma~or management
planning.
3) To detennine whether there is elartty in terms of roles and responsibilities for
in.nospilal risk factor management among cardiology staff induding cardiologists,
nurses, and dieticians.
1.3Ra_
It has been established that management of can:iovasoJIar ristl; fac::k:n is
_to_cantof~_ coronary hoart_ (5.6.7.8.9)
and lhallhe period of hospitalization lor acute myocanial~ oIIets a
unique window of opportunity 10 identify risk factors andi~ta risk
reduction strategy (21).
In any strategy to improve management of risk factors the obvious first step Is
that of identification of the risk factors. In the hospital environment, it isi~nt
that identified risk factol's are documented in the chartfmedical record.
This research will examine chart doQunentation of cardiovascular risk factors
and their management to detemine whether an in-hospital cardiovascular risk
factor management strategy was effective in i"1>fOYing assessment and
documentation of risk factors and their associated management
10
CHAPTER 2
BACKGROUND TO THE STUDY AND LITERATURE REVIEW
II
2.0 BacKground to the study and literature review
In a previous 1999 chart review~eted by the researcher in AMI patients at
the GHHSC, it became evident that lack of documentation of risk factors was
frequent. When abstracting for risk factors within the hospital record, the question
persisted: if there is no documentation of a risk factor, does that mean that there
is no risk factor? Oearty that could be a very dangerous assumption. Complete,
accurate and timely documentation is an essential part of the practice of
medicine. l"1>f'O'Ied documentation may improve continuity of care for current
and subsequent hospitalizations and improve the accuracy of recon:I information
used for quality measurement systems (24, 25). It seems reasonable that before
a strategy to manage risk factors can be implemented in the hospital setting,
some process to ensure accurate and complete documentation of risk factors is
required.
2.1 Cardiovascular risk factors
Secondary prevention measures have been widely researched and discussed in
the literature. Cardiovascular risk factor management provided by a team of
cardiovascular specialists induding physicians, nurses, dieticians, and perhaps
others such as behavioral therapists, is considered optimal (7). Despite evidence
for the efficacy of secondary prevention strategies, they are frequently
12
underutilized (36.37) and adherence over the long tenn. when ifT1)lemented.
remains low (37, 38).
The National Cholesterol Education Program (NCEP) Adult Treatment Panel II,
which is an expert panel established in the US by the National Heart. Lung and
Blood Institute (NHLBI) (46) defines positive cardiovascular risk factors as:
Non-modifiable
Age (male 2: 45 yrs, female Z': 55 yrs or premature menopause without
estrogen replacement therapy).
• Family history of premature CHD (definite MI or sudden death before 55
yrs in father or other first degree male relative or before 65 VB in mother
or other first degnte female relative)
Modifiable
Current cigarette smoking
Hypertension
Diabetes
Oyslipidemia
Sedentary lifestyle and stress have also been identified as contributors to
cardiovascular risk (47).
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2.1.1 Modifiabfe cardiovascular risk factprs
2.1.2 Smoking
Current cigarette srnolQng is defined as smoking one or more cigarettes per day
(73). The 27" Bethesda Conference Task Force. based on observational studies
that are considered conclusive. suggests that cigarette smoking increases the
risk for cardlovasCl.iar disease (7). Ar1 average smoker dies three years eartier
than a nonsmoker. while an individual known to be at high risk for cardiovascular
disease dies 10-15 years eartier if helshe smokes (60,61). Smelting actually
intensifies the effects of other risk factors, thus accelerating the progression of
atherosclerosis and innuencing occurrence of acute cardiovascufar events (62).
Smoking cessation. although surprisingly not systematically evaluated in patients
with heart disease. has been noted to result in as rruch as a 50% decrease in
mortality (37.39.40). Much of the benefit of smoking cessation occurs within the
first several weeks to months. but further reduction in cardiovascular mortality
accrues as a late benefit Risk. of cardiovascular mortality is thought to assume
that of a non-smoker after several years of non-smoking (7.87).
2.1.3~
Hypertension is a cardiovascular risk factor thai can lead to heart attack. stroke.
heart failure. kidney damage and death (52). Numerous dinical trials and meta
analyses, involving thousands of patients, have shown that treatment of
hypertension can decrease ri$k for these events (53.54,55.56). The sixth report
of the Joint National Comminee on Prevention, Detection. Evaluation and
Treatment of High Blood Pressure (JNC6), whidl includes a comminee of
experts established by the US National Heart, Lung and Blood Institute (NHLBI),
defines hypertension as systolic blood pressure of 140 nm Hg or greater.
diastolic blood pressure of 90 mm Hg or greater. or the use of an anti·
hypertensive agent (53).
The goals of treatment for hypertension indude:
Prevention of roorbidity and mortality from cardiovascular events (53).
Blood pressure less than 140J90 (52.53)
Blood pressure less than 130/80 for diabetics (52).
Blood pressure of 130/80 or less for patients with non-diabetic renal
disease (52).
Blood pressure less than 125175 for renal disease patients with
proteinuria greater than 19Jday (52).
2.1.4 Diabetes
It is estimated that diabetes, a major risk factor for CVO, affects approximately
two million Canadians (57). Cardiovascular disease is the cause of 75-80% of
hospitaNzations and of deaths in the diabetic population (58). The presence of
IS
diabetes has been shown to result in a two to three fold risk for c:ardlovaSOJlar
disease (32,33.34). In a recent study, Lundberg et aI. (35) investigated diabetes
as a risk fac:tor for AMI from a population perspective in Northern Sweden. The
study Induded B representative sample of 2432 men and women between the
years of 1990 -1994 and a post~AMI population of 3031 patients between 1989
- 1993. The overall mortality rate post-AMI was four times greater in men and
seven times greater in women. In the diabetic vs. non-diabetic population. The
authors concluded that diabetes inaeases the risk of AMI.
A recent large study, the Impact of Diabetes on Long Term Prognosis in Patients
With Unstable Angina and Non-Q-Wa.. 1.11 (75) prospadiwly galherad da" from
8013 patients in six countries to determine the two year prognosis for diabetic
and non.diabetic patients who were hospitalized with unstable angina or non-Q-
wave AMI. Another study. the Mortality From Coronary Heart Disease in Patients
With Type 2 Diabetes and in Non-Diabetic Subjects With and Without Prior MI
(74) compared the seven year incidence of AMI among 1373 non-diabetic and
1059 diabetic patients, aU from a Finnish population based study. Both studies
concluded that diabetic patients without previous vascular disease have as high
a risk of developing vascular disease, such as AMI. as non-diabetic patients with
pre-existing vascular disease. These data have stimulated discussions as to
whether diabetic patients should be treated as aggressively as secondary
prevention patients Vt'ho have had a previous AMI.
"
The Diabetes Control and Complications Trial (oceT) (59) examined whether
intensive glucose control could decrease the frequen<:y and severity of diabetic
complications. A toIal of 1441 patients with insulin-dependant diabetes mellitus
(100M) 'N8I'8 induded in the study which determined that intensive therapy to
control glucose levels delayed the onset and skJwed the progression of ciabetic
retinopathy, nephropathy and nelXOp8thy in patients with 100M. SimiJarty, the
Unled Kingdom Prospective Diebete. Study (UKPDS) (76), prospedively
examined 3867 ll8Wly diagnosed type 2 diabetic patients. The study reported that
improved glucose controf prevented the microvascular complications of insulin
dependant diabetes mellitus (100M), such as retinopathy. nephropathy and
neuropathy. However, tight glucose control was not shown 10 significanUy reduce
macrovascular complieations induding cardiovascular outcomes such as AMI
and CV mortaJity, reinforcing the need for aggressive cardiovascular risk factor
management in diabetics.
In terms of normalizing glucose levels. the 1998 Canadian guidelines (57)
provide a system for dassification of varying levels of fasting glucose and
glycated hemoglobin (HBA1c). This system is shown in Table 2.1.
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Table 2.1: levels of Glucose Contror for Adutts and Adolescents with Diabetes
Mellitus·
Glucose level
Parameter
!l!H! QoIi!!!l!!
- -(nannal (ta.... (action may <action
nondiabetic) goal) be raquired) required)
Glycated Hemoglobin - HbA'e 0.04-0.06 <0.07 0.07-0.084 >0.084
Fasting or premeal glucose 3.8-6.1 4.0-7.0 7.1-10.0 >10.0
level (mmolll)
Glucose level 1·2h after meal 4.4-7.0 5.0-11.0 11.1·14.0 >14.0
(rrvnoIIL)
·(adapted from reference #57)
Diabetes remains a risk factor for poor outcomes in patients with established
coronary artery disease (7). Haffner et a!. (74) showed that the seven--year rate of
major cardiovascular events for diabetics with previous myocardial infarction was
similar to that reported for diabetics in the Scandinavian Simvastatin Survival
5tudy (45), at 45%; this compared to a rate of 18.8% in non-diabetics with prior
myocardial infarction. The 45 study (42) was a landmark trial designed to
evaluate the effect of lipid lowering therapy in 4444 patients with coronary heart
disease. A post hoc subgroup analysis (83) was carried out on 202 diabetic
patients and 4,242 non-diabetic patients. The authors concluded that the
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absolute dinical benefit d lipid lowering in this high-risk population may be
greater in diabetics versus non-diabetics due to their absolute increased risk tor
recurrent events. Similar to other trials (n,78), diabetics in the 45 study and the
study by Haffner et al. also had a m.K:h higher rate d mortality from CHD than
non-diabetics.
A recent study by The Heart Outcomes Prevention Evaluation (HOPE) study
investigators titled, Effects o(an AngiotfH1sin Converting Enzyme Inhibitor,
Ramipril, on cardiovascular EvJnts in High Risk Patients, (81) measured
outcomes including death, myocardial infarction and stroke in a broad range of
high-risk patients from almost 300 centers in North America, Europe, Argentina
and Brazil who did not have heart failure or low ejection fractions (conditions
normally requiring treatment with an angiotensin converting enzyme inhibitor,
such as Ramipril). Indusion criteria for the HOPE trial were, men and women
who were at leasl55 years of age with a history of: CAD, stroke, peripheral
vascular disease, or diabetes p'us at least one other cardiovascular risk factor.
There were a total of 9297 patients induded in the study, 35n had diabetes. The
incidence of composite outcomes (MI, stroke or death due to cardiovascular
causes),in the diabetic population was19.8%, which is much lower than the 45%
rate reported in the two previous trials. This rate of events was not significanUy
different from the rate of 16.5% seen in norH:liabetiC HOPE patients, suggesting
less risk for diabetics than previously reported. However, of the 35n diabetics,
"
1135 of them had no dinical manffeslation of cardiovascular disease. Their rate
of events was neafly haff that of the group with dinical manifestations (10.2 % vs.
18.7%), supporting the hypothesis of increased risk if patients have both
established cve (sudl as the post AMI populations of the Haffner and 45 bials)
and diabeles.
In summary. numerous trials suggest that attention to cardiovascular risk factor
management and optimal control of diabetes (i.e. tight glucose control) are
extremely ifl'1)Ortant in diabetic patients with established coronary artery disease.
2.1.5 Dysrpidemia
Oyslipidenia is the term generally accepted to describe an abnormal lipid profile.
Elevated LDl-C and deaeased HOl·C are considered major risk factors for
carctiovascut8l" disease. Hypertriglyceridemia is associated with compositional
changes in LDL-C resutting in smaUer and more dense partides which are more
susceptible to oxidation and thus believed to be particularly atherogenic (7). The
relationship between triglycerides and coronary heart disease has been difficult
to elucidate and to date remains controversial. Clinical trials have not
demonstrated the benefit of triglyceride lowering. however. observational studies
have suggested triglyceride elevation as a risk factor in subsets of patients.
especially those with low HDL cholesterol. (63.64.84).
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Management of hypet1ipidemia in the secondary prevention of heart disease has
been proven to decrease the risk for morbidity and mortality (7). Over the past
decade Iatge landmartc. clinical trials such as the previously discussed
Scandinavian Simvastatin Survival Study (4S), the Cholesterof And Recurrent
Events trial (CARE) (85) and the Long Term Intervention with Pravastatin in
Ischemic Disease (lIPID)Triai (86), have demonstrated that statin drugs
(Simvastatin and Pravastatin respectiv"y), initiated three to six months after AMI.
significantly reduce morbidity and mortality in patients with established coronary
artery disease, probably by reducing the risk for plaque rupture by stabilizing
wlnerable plaques (37, 41, 42).
The CARE trial (85) was a five-year double blind placebo controlled trial.
designed to examine the effect of lowering cholesterol in patients with coronary
artery disease who had average choIesterof levels, rather than IHevated levels.
There were 4159 men and women included in the study which demonstrated that
the benefit of cholesterol lowering extends to patients with coronary artery
disease who have average levels; this group of patients represents the majority
of patients with coronary artery disease. The findings of this trial allowed the
benefits of lipid lowering to be expanded to a very large population of high-risk
patient The LIPID trial (86) was also a doubJe blind placebo controlled trial. tt
examined 9014 patients who were followed for six years and it determined that
there were statistically significant mortality and morbidity benefits in patients 'Nith
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AMI or unstable angina who had a broad range of initial cholesterol levels.
In April 2001. results of the MIRACLE Study. Effects of Alorvastatin on Earty
Recurrent Ischemic Events in Acute Coronary Syndromes, were reported (89).
This randomized, placebocootrolled trial induded 3086 adults ages 18 years or
older and examin~ earty intervention with a statin in patients with acute unstable
angina or non-Q·wave AMI. This trial was of sixteen weeks duration and the
results demonstrated benefit, in lerms of reduced recurrent symptomatic
ischemic events requiring emergency re-hospitalization (p=O.02), within a 16
week time-period.
In summary. many thoosarxts of patients, in many countries, have been
examined in large, randomiZed, placeb<H:ontrolled trials, which have consistently
concluded morbidity and mortality benefits in high-risk patients with established
CAD who received slalin therapy to manage their lipid levels.
Table 2.2 illustrates target lipid levels for patients, depending on their predicted
degree of risk over the next len years as well as presence of diabetes or CVD.
Patients with established CVD, such as those examined in this research, are
considered very high risk.
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Table 2.2: Target lipid Values by level of Risk-
level of risk (definition) lOl-C level, Total
mmoVL cholesterol:
HDl-e ratio
Very high <2.5 <4
(lO-yr risk of CAD >30%, or
history of CVO or diabetes)
H;gh <3.0 <5
(1o-yr risk 20-30%)
Moderate <4.0 <6
(lO-yr risk 10-20%)
Low <5.0 <7
(10-yr risk <10%)
*(Adapted from reference #66)
2.1.6 Sedentary lifestyle
Triglyceride
level,
mmollL
<2.0
<2.0
<2.0
<3.0
Exercise education is considered a key service of any comprehensive cardiac
rehabilitation program (44).
It is difficult to measure physical activity and quantify the relationship between the
amount of exercise and the risk of coronary heart disease. However, over 50
studies have established ltIat physical activity reduces the risk of coronary artery
disease events (7,40,65). Some examples of research results on the topic of
sedentary lifestyle are seen in a population based cohort study performed in
Norway, where 5220 men and 5869 women aged 20 to 49 years at ltIe time of
entry were surveyed at two time periods (1979 -1980 and 1986 - 1987). Self
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reported leisure time activity, as well as body mass index (8MI) and lipid levels
were assessed. The authors conduded that sustained high levels of activity and
change from sedentary to higher levels or physical activity resulted 8MI and lipid
parameter benefits to both men and women (88). Simitarty, n35 men aged 40-
59 years in Britain were studied to assess the relationship between physical
activity and changes in activity, all cause mortality, and the incidence of major
coronary heart disease. The study detennined that maintaining or beginning light
or moderate physical activity reduced mortality and AMI in men with and without
clinical evidence of cardiovascular disease (51).
Modifrcation of risk factors, either singly or in combination, in the population with
esta~ished coronary artery disease is considered a powet1ul method of reducing
the risk of morbidity and mortality, comparable for instance, to such interventions
as bypass surgery (45).
2.2 In.-hospital risk reduction strategies
The current focus of hospitalization in the post AMI period is largely one of
treatment rather than prevention, although it has been suggested that in-hospital
management of cardiovascular risk factors in the AMI patient may be the ideal
place to begin. The Joint European Task Force recommendations state that the
hospital is a good starting point for a rehabilitation program and that this program
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needs 10 be bridged to the community 10 provide continuity of risk factor
management (21). During the aaJte in-OOspital phase. patients may be
preoccupied and their degree of receptiveness to education programs is not fully
understood. However. surveys such as HELP (Heart European Leaders Panet)
have shown thai patients listen 10 the advice thai hospitals provide. Thai insighl
suggests there is good reason for treating cardiologists 10 ensure patients ~ave
hospital with appropriate advice and treatments thai are optimany followed up by
primary care (16,17,28). It has been suggested that the lack of urgency 10 initiate
in.hospilal risk factor management planning signals to primary care physicians
that it is less than high priority. Furthermore. a delay in communicating often
means the impetus to initiate a follow up plan is lost (16,26).
Recognizing that reasons for lack of optimal anention to cardiovascular risk
factors are likely multifactorial. one suggestion has been thai hospitals are often
not organized wei enough to provide preventive care (16,17). Perhaps
preventive care has not been seen as part of the hospital mandate. leaving the
major focus on treatment versus prevention. The emphasis on earty discharge
means there is limited opportunity for busy cardiologists 10 provide advice about
the benefit of risk reduction. The focus of the hospitalization is not on risk factors,
but the acute manifestation (16,17). Currently, work is ongoing to improve the
process of risk identification. documentation and management in the acute
hospitalization period. One example of StJch an initiative is ongoing in Nova
"
Scotia. A number of hospitals participating in the Improving cardiovasaJlar
Outcomes in Nova Scotia (ICONS) project have developed various custom made
standard chart forms. capturing risk factors and requiring a OOCtor's sign off pre·
discharge; copies are then sent to primary care physicians. It may be that such
interventions will improve management by ensuring treating physicians are
aware of patients' risk factors. whie also bridging to the community for long term
management (31). Follow-up of this work is ongoing.
There is very little information available pertaining to the roles and responsibilities
of various cardiok>gy staff members including cardiok>giSIS. nurses and
dieticians, in terms of cardiovascular risk factor identification, documentation and
management. In the busy environment of acute hospital care, cardiology staff
members have very limited time. which is often spent responding to acute
lifesaving situations. Although not acutely a priority. management of risk factors
today may avoid sudllife saving crises in the future. A process which facilitates
attention to risk factors that is understood by all cardicMogy staff should allow for a
more effICient method of establishing a risk reduction strategy for each AMI
patient pre-discharge. one that is communicated to primary care, to aUow for long
term follow up and management. This process requires further research.
2.2.1 In-hoscitallipid lowering treatment
Many hospitals have initiated routine standing orders to measure lipid profiles
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within 24 - 48 hours of AMI in an attempt to identify higll-risk patients needing
aggressive lipid management and to intervene early (31 ,SO); this practice is not
without some debate. The NCEP treatment guideWnes, for example, have
recommended delaying baseline tipid measurement until six 'Neeks post aQJIe
event, recognizing that the acute--phase re5JXMlse triggered by AMI can
potentially lower total and LDL cholesterol (46). Such delay means the time to
intervene occurs after leaving hospital, when the patient may be less focused on
the importance of the issue and in a setting of lesser resources (48).
Lipid profiles obtained within the first 24-48 hours of admiS$k)n for AMI in a
. number of studies (49, SO) have demonstrated consistency when compared to
steady state levels at two to three months post-discharge, thus removing some of
the perceived barriers to early intervention. However, it must be recognized that
if the lipid profile is obtained after 48 hours of the event, the results can be
misleading. Examptes of two studies that reported on the timing of lipid profile
measurement post-AMI indude 1) Plasma lipids: when to measure after
myocardial infarction? (SO) and 2) Clinical utility of lipid and lipoprotein levels
during hospitalization for acute myocardial infarction. (49). The former study
examined plasma lipids in 132 post AMI patients on admission and 24. 48 and 72
hours later; 103 of these patients also had lipid measurements at three months.
The latter study examined in-hospital lipid levels (within 48 hrs versus after 48
hours) compared to post discharge levels (2-3 months post discharge) in 294
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patients at the Brigham and Women's Hospital in Boston. Both studies concluded
that lipid profiles shoukt be measured within 48 hours of admission for AMI.
The decision of when to manage lipids after AMI becomes a choice between
early intervention with folow up by the treating cardio'ogist, 01 later intervention
with fo'low up by the treating cardio'ogist or family physician. Without
communication between the specialist and primary care family physician. the
opportunity to intervene may be missed.
A university hospital program in Califomia, Cardiac Hospitalization
Atherosclerosis Management Program (CHAMP), that focused on initiating lipid
lowering treatment in AMI patients before discharge, preliminarily reported a
significant inaease in treatment rates, improved patient comp{iance and an
increased number of patients reaching target lOllevels (SO). Very recently, in
April 2001, CHAMP reported improved utilization of evktence- based therapies
post.AMI (Aspirin, Beta Blockers, Nitrates, Angiotensin Converting Enzyme
Inhibitors and Statins) optimized through the use of an in.hospital treatment
algorithm strategy. This increased utilization of proven therapies was associated
with significantly improved clinical outcomes in the year after discharge including
decreases in rates for recurrent AMI, heart failure, hospitalization, sudden death,
cardiac mortality, non-cardiac mortality and total mortality (79).
"
On a broader, population sca~, a team of Swedish investigators completed a
prospective cohort study using data from the Swedish Register of Cardiac
Intensive Care on patients admitted to coronary care units of 58 Swedish
hospitals between 1995 and 1998. They obtained one-year mortality data from
the Swedish National Cause of Death Register. It was conduded that earty
treatment with a statin (at or before hospital discharge) in patients with AMI is
associated with reduced one-year mortality. At one year, unadjusted mortality
was 9.3% (1307 deaths) in the no-statin group versus 4.0% (219 deaths) in the
statin treated group. This reduction in mortality was similar among all subgroups
based on age, sex, baseline characteristics. previous disease and medications
(67).
In a recent correspondence to lancet, Missouris and MacGregor (30) described
frndings pertaining to in-hospitallipid management post AMI. In a 1996 CCU
chart audit at SI. George's Hospital in London. UK it was identified that only 13%
of post AMI patients were discharged on a stalin drug despite an 89% rate of lipid
measurement due to CCU admission protocol. By empowering CCU nurses to
constantly remind medical staff to start a stalin when indicated. before discharge,
a follow up audit in 1998 showed that more than 68% of patients were
discharged on a slatin drug. This simple maneuver of empowering nurses
provided the extra push required 10 achieve improved lipid management.
,.
2.3 Chart non-documentation
During chart abstraction for the current research, there were frequent
occurrences when no mention was made of cardiovascular risk factors.
Quality of medical care is frequently assessed by measures of structure, process
and outcomes of care (69). Although critical indicators of care, outcome
measures may take years to develop and certain endpoints occur only rarely. For
instance, acute coronary syndromes, stroke and death are rare Iong~tenn
outcome consequences of hyperlipidemia. They are not useful endpoint
measures for shorNenn trials assessing cardiovascular care; on the other hand,
processes of care, such as completeness of history and physical chart
documentation, appropriateness of therapeutic care and follow-up can be
assessed immediately. These measures of care process are only meaningful if
they can be linked with outcomes (70). Investigation of this link requires further
research.
II seems reasonable to expect that data pertaining to cardiovascular risk factors
would be easily obtained from the patient chart. The chart is the ultimate
information source for many purposes induding: to recall observations, to inform
others, to instruct students, to gain knowledge, to monitor performance and to
justify interventions. Patient care planning for the short and long term should be
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evidenced within the chart (72).
Recently investigators from the ICONS project presented an abstract at the 1999
Canadian Cardiovascular Society (CCS) annual meeting, which identified lack of
documentation of cardiovascular risk factors in the hospital charts of
cardiovascular patients in Nova Scotia (23). Specifically, in the AMI population,
(at the time of this abstract 1187 patients had been induded for analysis)
smoking status was not documented in 6% (n=71), diabetes status in 24%
(n=285), cholesterol status in 27% (n=320), hypertension status in 19% (n=226)
and presence of famity history in 59% (n=7oo) of cases. Another study, a British
Cardiac Society survey of the potential for secondary prevention of coronary
disease, ASPIRE (Action on Secondary Prevention through IntetVention to
Reduce Events) (22) found that recording and management of risk factors
including lifestyle, blood pressure, cholesterol, and glucose were less than
optimal in hospital records. The authors conduded that a mOl'e structured
approach, or process, is needed to ensure the identification and management of
risk factors. Secondary prevention measures should begin as soon as the
diagnosis is made, and shouldn't be postponed until the patient deteriorates to
the point of needing bypass surgery.
A team of researchers in Illinois investigating whether a computer-based patient
record (CPR) affects the completeness of documentation and appropriateness of
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documented clinical decisions found that with more complete documentation,
more appropriate clinical decisions were made, as judged by an expert paneL
Four b'inded expert reviewers evaluated 50 progress notes of patients with
chronic diseases and whose physicians used either a CPR or paper record. The
authors found that physicians who used the CPR vs. paper reoords, documented
p~m lists and medication lists more completety (1.7912.00 vs. 0.9312.00,
p<0.001), provided more evidence in their documented assessment that they had
considered relevant factors in their decision·making (1.5312.00 vs. 1.07/2.00,
p<0.OO1) and they documented more appropriate decisions (3.63/5.00 vs.
2.50/5.00, p<0.OO1). The authors argue that improvement in documentation is
improvement in practice (72). Further research is needed to determine whether
improved practice translates into improved dinical outcomes.
One example of the implementation of chart forms to improve the process of in-
hospital education was published in 1998. The authors described the need to
improve the process of education defivery in an environment of inadequate
patient knowledge and goal setting as wei as decreasing length of stay at their
hospital in New Jersey, USA. The patient hospital charts were reconflQure<t to
include a central location for patient education documentation forms. A review of
almost 900 patient charts revealed an increase in documentation rate from 41 %
in the summer of 1995 to 93% in the fall of 1996. All pertinent disciplines were
involved in decision making throughout the process of development and
implementation of this continuous quality improvement (Cal) initiative (29).
2.4 Summary
Review of the literature demonstrates unequivocal benefit of management of
modifiable cardiovaSOJlar risk factors, including cigarette smoking, hypertension,
diabetes, dys/ipidemia and sedentary lifestyle. Despite evidence that reduction of
these cardiovascular risk factors posiUvely impacts morbidity and mortality in
patients with established coronary artery disease, the current management of
these risk factors is less than optimal.
Patients with AMI are at inaeased risk for progression of disease and recurrent
events. Many trials have identifted interventions such as smoking cessation,
hypertension management, lipid management and exercise regimens, as tools to
reduce risk in this high-risk population. The resulting combination includes a
higtHisk popOOiOOn and proven interventions for benefit. This should underscore
the need to ensure management of cardiovascular risk factors in AMI patients as
a priority.
The issue of when and where a cardiovascular risk reduction strategy should
begin has been examined. One model presented is an in-hospital post AMI
strategy, which represents an opportunistic top down approach. It is recogniZed
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that this is one of many potential models with the limitation of capturing only
those patients admitted to hospital with an acute event. However, it may be that
hospital is the ideal place to begin a risk management plan that is bridged to the
community primary care physician for long-term follow-up and management.
Other models, capturing the majority of high-risk patients in the community, are
important and warrant further investigation.
The patient's hospital chart is the ultimate source of information that is used for
numerous purposes, including patient management planning. Although not
widely discussed in the literature, it is intuitive that quality of chart documentation
witllead to quality patient care delivery. The current research will assess
whether an in-hospital cardiovascular risk reduction strategy improved
documentation of cardiovascular risk factors and their management. Further
research is needed to assess whether improved documentation leads to
improved quality of care and outcomes.
CHAPTER 3
METHODS AND PROCEDURES
"
3.0 Methods and ProcedUI'8$
Chapter ttwee Is a presentation of the methods and procedures of the study. For
the purpose of presentation, the chapter has been divided into five sections: I)
Introduction ii) description of the populations iii) description of the researc:h tools
utilized Iv) desaiption of the procedures and v) description of data analyses.
3.1 Background for study methods
In December 1998, staff at the GHHSC initiated a~ cardiovascular risk
reduction strategy for post AMI patients. The strategy induded 1) measurement
of lipid profile within 24 hours of admission and 2) the addition of three chart
forms 8) Cardiovascular Risk Factor Profile (see appendix G), b) Cardiovascular
Risk Factor ManagelTlflnt Plan (see appendix H) and c) Cardiac Education
Record (see appendix I). By measuring lipids within the first 24 hours of
admission, elevated levels could be brought to the attention of treating
cardiologists, nurses and dieticians. increasing the likelihood of lipid
management. Completion of the three risk factor chart forms was an attempt to
Increase identification. documentation and management of risk factors.
Completion of the chart forms was the responsibility of nursing/dietician staff and
sign off by treating cardiologists was not necessary. The beneficial effect of the
strategy could be limited due to lack of physician Involvement. Cardiotoglsts,
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through completion ofdischarge sunvnaries and letI8rs, .. the link to
community primary care, making their involvement in risk management essential.
The routine standing order for lipid profile measurement was included on the
CCU adrrission order form for AMI patients. The three chart fomIS were located
on the cardiology 1I00r and the nurse or dietician co"'4lleting the forms was
responsible to add the forms to the patient chart.
3.2 Description of the Populations:
The study popUations for this research include post·AMI patients examined
within the chart review portion (phase I) of the study and cardiology staff
members included in the survey questionnaire portion (phase II).
3.2.1 PopUlation for phase I:
The target population for this cross sectional descriptive study included all
patients discharged from the GHHSC with a ·most responsU)le discharge
diagnosis· of Acute Myocardial Infarction. ICD 9 code 410. Charts of patients
meeting that criterion for two separate time periods. before and after
i~ementation of an in hospital cardiovascular risk management strategy in
December 1998. were reviewed. In an effort to e1irrinate any affect of
seasonality. the following compIele year time periods were selected for
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exanW1ation:
The before group: Juno 1. 1997 - May 31. 1998
The _group: June 1. 1999· May 31. 2000
TIme constraints did not permit review of aft AMI patients. h was therefore
_that selection of Ihose with.·.....__dischaIge diagnosis' of
AMI would answer the needs of this research. It is important, however, to nole
that this study will not examine patients who experienced AMI as a secondary
diagnosis. Although an importanl group, desefving the same attention 10
cardlovascufar risk management, It win not be included within the scope of this
study.
Tabfe 3.1 represents the population examined in phase I of the study:
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Tabte 3.1 - study poptJIations in the before group and the after group:
Table 3.2 lists reasons for exclusion from the study and details the numbers
excluded in each group.
"
Table 3.2: Excluded patients:
Reasons for exclusion
1) For palliative care only
(No code 9 order on chart)
2) One day transfer patient
(ie. for cath from another site)
3) Self-discharged within 48h
Total
3.2.2 Pooulatlon for phase II:
After group
14
The target population for this cross sectional descriptive study induded fun time
and part time cardiofogy staff working ClIT8f1dy, and for at least the past three
months, on the cardiofogy ftoor at the GHHSC. Of the total nine cardiofogists on
staff at the GHHSC, one cardtologist did not have CCUISSA (cardiology noor)
responsibilities, making eight cardiofogists available for inclusion. Of the 52
nurses on staff, two nurses were not available due to long term sick leave and
seven \Yare excluded due to having less than three months experience on the
unit. leaving 43 nurses avaHabie for inclusion. There was one dietitian on staff for
inclusion. Tabkt 3.3 details the distribution of SlM'V8y questionnaires.
..
Table 3.3 Total number of survey questionnaires distribl.ded :
Total number of survey questionnaires
disbibuted:
52(100%)
8 cardiologists (15")
43 nurses (83%)
1 d..6cian (2%)
3.3 Description of research tools utilized:
Two research tools were developed specifically for this study. There were no
formalized processes for validation of these fonns; rather, local face validity was
established as described below.
3.3.1 Post AMI cy Risk Management Chart Review FOrm (appendix C)
This Post AMI CV Risk Management Chart Review Form was utilized for chart
data abstraction. Based on a previous pilot study performed by the researcher,
the chart review form was revised to capture aN necessary variables retated to
risk factor identification, documentation and management in-hospital. The revised
chart review form was pre-tested on the first ten charts for both adequacy of
abstraction and compfetion of data entry. After a second revision, the chart
"
review form was accepted.
3.3.2 POSt AMI Risk Assessment Questionnaire (appendix O)
This Post AMI Risk Assessment Questionnaire was developed by the researcher
and piloted by five ICUfCCU nurses. Following severa l'8Yisions it was re-plioted
with three different mnes and one physician. II was then adopted as adequate.
3.4 Description of procedures:
Procedures for phase I and phase II are detailed in this section.
3.4.1 Pror.8dure fpr phase I'
Ethical considerations:
Ethical approval was obtained from the Human Investigation Committee (HIC) at
Memorial University of Newfoundland (MUN) (appendix A) and the Research
Proposals Approval Committee (RPAC) of the Health Care Corporation of 51.
John's (appendix B). Once ethics approval was confirmed, Ms. Ricki Fisher,
Supervisor for research and statistics at the GHHSC, was consulled. Ms. Fisher
generated the necessary lists of AMI patients for the required timeperiods.
For ethical and security reasons, no names were used on any abstraction forms;
rather, they were numericaUy coded. AU data were kept in a locked cupboard.
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Chat1 retrieval and tVriM':
All AMI patients at the GHHSC during the _mined time periods with •
discharge ICD 9 code 410 __ idonlifted. From thalli... charts which had • 410
code listed as the ·most responsib'e discharge cIagnosIs· were selected and
sequenced by cha1 nurmer tor record retrieval by medical records staff. During
the months of August through December 2000. the researcher independendy
reviewed charts and abstracted data.
Variables selected to assess identification and documentation of risk factors
indude(j: previous MI. pnMouS CAD. famity history of heart disease,
hypertension. diabetes, cholesterol and WT8f1I: smoking status.
Documentation of a risk factor was considered present if it was recorded
anywhere Yt'ithin the patient chart induding the discharge summary, physician,
nursing and/or dietitian notes and lab slips. The presence of a risk factor was
recorded as yes, no, unknown (patient unaware of status) or not documented.
The yes. no and unknO'M"l reSlAts were defined as the "total documented"
category, which was then compared to the "total non-documented- category.
Variables selected to detennine management of risk Inducted: evidence of lipid
measurement in hospital or within past three months (up to three months was
selected to accommodate ease of information retrieval), patient on lipid lowering
therapy at time of discharge<_ either _ or during hospitalization),
documented folow-up lipid plan (i.8. note Ie check 6pid profile in four to six
weeks), foIkJw-up smoking cessation ptan (i.e. note to diSQISS with farrily
physician or to try nicotine patch) evidence of stress counseting, smoking
cessation counseting, diet counseling and eX8ICiH counseling. For this research.
any attempt al counseling documented 'Mthln the chart was considef8d
counseling. For instance, if a physician mentioned to a patient that he sholJd quit
srnoldng, it was considered smoking cessation counseling.
Many factors could have been examined to determine predictability for
cardiovascular risk factor idenUftcation. documentation and management For this
study, however, only age (younger versus otder). sex (male versus female) and
location of the patient ( St John's and metro area, which for the purpose of this
research will be referred to as Central Health Region (CHR), versus non-eHR)
were examined with logistic regression analyses.
3.4.2 Procedure for phase II"
Ethical considerations:
In earty 0dDber 2000, having all required ethics approval, discussions were held
with Dr. Eric Stone, Chief, Division of Cardiology and Ms. Marle OuffeU. Nurse
Manager (Cardiology), to obtain pennission to contact staff to participate in this
research by completing survey questionnaires.
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To enslft total anonymity, no names were required and aI returned surveys
were coded numericalty. Survey response cards were dropped in separate
envelopes when COfT1)Ieted surveys were returned.
Survey distriblAion:
In October 2000 all cardiology staff received by internal mail, personany signed
letters of introduction from the researd'ler and packages (see betow) to facilitate
completion of the Post AMI CV Risk Assessment Questionnaires.
The mall out packages included:
A cover letter of introduction explaining the purpose of the questionnaire
and the importance of cardiology staff input for analysis of the amtnt
status of risk management at the GHHSC. Instructions for conJP'etion of
the survey questiomaire and drop off in dearty marked boxes at any of
three sites located on the cardioklgy floor, the EKG Department or the
Cardiac Catheterization Laboralory were described.
• The Post AMI Risk Assessment Survey Questionnaire.
• Although participation was voluntary and anonymous, survey response
cards titled, Confirmation ofSurwy Questionnaire Completion cards were
Induded In the package to be signed and dropped in separate envelopes
"
attached to each drop off box. This allowed the researcher to falow up on
questionnaires that were not returned.
For the information of staff being surveyed, copies of all three terms
utilized In the December 1998 in-h0spit8 CV risk management strategy
were included.
ISH appendices D,E.F,G.H,/, for compIeta mal out pacicaga).
Other efforts to optimize survey compIetiofl:
In November 2000, reminder letters (see appendix J) were sent by intemal
hospital distribution to indiViduals who had not completed and returned their
surveys, as evidenced by absence of signed survey response cards.
At the same time as the reminder letters were sent, the researcher posted
reminder slgns on the cardiologybr asking for staff partidpation in surVey
completion. Additionally, survey questionnaire packages were made available at
the January 2001 cardiology nurses staff meeting and lastly, personal contact
was made with four remaining cardiofogists to ask for their participation.
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3.5 Description 01 data analyses
All data WOl8 analyzed using the Sta_ Package lor Social Sciences (SPSS -
version 8). The phase I portion of the study required a corT1J8rison of the before
and after groups in terms of identification. documentation and management of
risk factors. For this. Chi-square analyses were utilized. The probability MtveI
needed for rejection d the null hypotheses. when !he null hypothesis is true, was
set at a.os.lndependent ~Ies T-Testwas used to compare average length of
stay (LOS) information. Logistic regression analyses were conducted 10 identify
independent variables associated with not implementing the risk management
strategy.
Phase II of the study required an analysis of SlJ'V8y questionnaires. Frequency
tables were used to analyze the survey responses, which are reported in
aggregate for the entire survey poputatioo to ensure anonyrrity. Each
questionnaire was reviewed by the researcher to capture data from the additional
comments sections, which are summarized in the results section of this paper.
CHAI'TER 4
RESULTS
..
4.0 Reslits
Following a review of demographic findings, this chapter has been divided into
three major sections, c:orresponding to the two objectives retating to the effect of
the in-hospital risk management strategy utifizing chart reviews in phase I and
the one objective relating to staff perceptions utilizing survey questionnaires in
phase II.
4.1 Phase I demographic findings
A total of 324 charts were Identified as having a Mmost responsible discharge
diagnosisM of AMI. Of those, there were 49 in-hospital deaths and 2S charts were
excluded (see table 3.1). Information was therefore cotlected on a total of 250
patients; 114 in the before group and 136 in the after group. The before group
median age was 60 years (range 32 - 87 years) and the after group median age
was 67 years (range 24 - 90 years). Since no age restriction was applied to the
in-hospital risk management strategy, no age exclusion was applied for this
study.
One analysis considers age in two categories, a) less than or equal to 70 years
and b) older than 70 years. There was a significant increase in the proportion of
elderly AMI patients from 25% in the before group to 42% in the after group
••
(p < 0.006). As well. !he female propo<tlon 01 !he AMI population increased fn:>m
31 % before to 35% after (not statistically significant). The GHHSC is the tertiary
center for Newfoundland and Labrador, thus the primary refenal center for the
province. There was no significant maeas8 in the number of patients
hospitalized at this center from outside the 51. John's and metro area (Central
Health Region - CHR). The number of patients from other than the CHR in the
before group was 22% vs 25% fn the after group. (See table 4.1)
Table 4.1 Characteristics of patients In phase I analysis
Befo<e Group
n(%)
114(100)
After Group
n(%)
136(100)
Statistical
stgnificance
p Value
(6 before/after)
Age s70yrs 85(75) 79(58)
> 70 yrs 29(25) 57(42) 0._·
Sex Male 79(69) 89(65)
Female 35(31) 47(35) 0.518
Location CHRt 90(78) 102(75)
Other than 24(22) 34(25) 0.461
CHR
• Chi-Square statistical significance if p < 0.05
tCHR = For the purpose afthis research. central Health Region indudes SI.
John's and metro area, Other than CHR • all other regions within the province of
Newfoundland and Labrador.
The in-hospital AMI mortality rate at the GHHSC decreased over the time span of
this research. The in-hospttal mortality tor the study population. (AMI -most
responsible discharge diagnosis1 _sed from 18% to 13%. l.eng1ll of Slay
(LOS) deaeased somewhat over the time period of this research. The average
LOS in the before group was 8.8 days versus that of the after group at 8.4 days.
Neither deaeases in mortality or LOS reached statistical significance (See table
4.2).
Table 4.2 Mortalijy and average length of Slay findings for sludy population
Before Group A1terGroup Pvalue
n(%) n(%} (d
114(1001 136(100) beforeIafler)
Deaths 27(18} 22(13} 0.136
Length 8.8 Days 8.4 Days 0.625
of stay
Chi-square statistical significance if p < 0.05
4. 2 Results pertaining to phase I:
4.2.1 Beforelafter analyses pertaining 10 identification and chart documentation:
Of the variables selected to determine identification and documentation of
cardiovascular risk factors induding previous MI, previous CAD, positive family
history, hypertension, diabetes, .evated cholesterol and aJrrent smoking status,
Sf
onty one YIWIbIe. docunwlt8tion of previous CAD, reached a JeveI of statistic:3
sigRficance in tho _ group (p =0.0<9). Doc:lonontlItio of pt-.ious MI and
cholesterol status showed a positive trend. otherMse ch8rt8d variables were
IlIIgeiy unchanged (see table 4.3).
"
Table 4.3 CardiovaSCliar risk factor documentation comparison between groups.
for total documented versus total not documented:
RiSttFactor
......"""'"
-G<oup PV...
nl"J nl"J (AbeforeIafter)
114(100) 136(100'
PnMousMI V.. 28(25J 38{28J
No .at"J 65(48J
U,*,- O(OJ 0(0)
T.... """ 76(67) 103(76)
... """ 38{33J 33{2'J 0.113
_CAD
V.. 42(37) 58(43)
No 43(38) 57(42)
"""'-
0(0) 0(0)
T.... """ 85(75J 115(85)
... """ 29(25) 21(15) ......
Positive f.my tistory V.. OO(53J 76(56J
No 28(25) 26(19)
"""'- 2(2) O(2J
T.... """ 89(80) 103(71)Not""" 25(20J 33(23) 0.575
-
V.. 42(37) 61(4.5)
No 49(43) 49(36)
Uri<.... 0(0) 0(0)
T.... "'" 91(80) 110(81)
... "'" 23(20J 26(19) 0.834
Diabetes Vn 31(27) 29(21)
No $8(51) 73(54)
UM"" 0(0) O(OJ
Total Doc 89(78) 102(75}
... "'" 25(22) 34(25} 0.569
Elevated Cholesterol V.. 28(25J 43(32)
No 16(14) 26(19)
"""'- 39(3<J 36(22)
T.... "'" 83(13J 105(78)
... "'" 31(27) 31(22) 0.422
CWTentsmokel' V.. 48(<42) 53(39J
No 51("6} 67(49)
U........ O(OJ 0(0)
Total Doc 99(82) 120(88)
..."'" 15(13) 16(12) 0.739
• Chi-square statistical significance if p< 0.05
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4.2.2 BeforeJafter analyses for in-hospital cardioyasgJ!ar risk management"
Variables selected to determine mBnagement of risk fadOrS induded:
measurement of lipid stabJs in hospital or within three months prior to
hospttaJization, presence of lipid lowering therapy (LlT) at discharge (unless
reported values were within recommended l&viMs). dietary coooseling, stress
management counseling, exercise counseling, smoking cessation counseling (if
identified as a smoker), documented plan for follow up of lipid status and
documented plan for smoking cessation foflOW-up.
Attention to lipids, including measurement of lipids and percent of patients on
lipid lowering therapy at discharge were both statistically significantly increased
in the after group compared to the before group (64.0% VI 20.0% and 31.0% VI
11.5% respectively at the p < 0.001 level in both cases). Smoking cessation
counseling increased significantly from 24.0% to 48.0% in the after group (p <
0.001) while stress management counseling increased from 4.0% to 21.0% in the
after group (p < 0.001). However the numbers of patients with doaJmented
counseling for smoking cessation and stress management were quite small,
ranging from a low of five in the before group for stress counseling to thirty three
in the after group for smoking counseling. In terms of a documented plan for lipid
follow-up and documented plan for smoking cessation follow-up there were no
differences in the before and after groups. The results for non-documentation of
dietary and exercise counseling showed significant differences, however.
contrary to Intuition, both demonstrated Increased documentation In the befofe
group vs after (11.5% y.s.28.0% and 20.0% Y.s.32.0% respectivefy p < 0.001 in
bolh cases) (see table 4.4),
Table 4.4 Comparison of documented cardiovascular risk factor management
Before -, P value
Group Group (0 beforeIafter)
n(%) n(%)
114(100) 136(100/
Lipid measure Ves 23(20) 87(64) <0.001·
No 91(80) 49(36)
On LLTal discharge Ves 13(11.5) 42(31) <0.001·
No 101(88.5) 94(69)
Stress counseling Ves 5(4) 28(21) <0.001·
No 109(96) 108(79)
Smoking counseling Ves 15(24) 33(48) <0.001·
No 48(76) 36(52)
FlU Lipid plan Ve. 35(31) 31(23) 0.470
No 79(89) 105(77)
FlU Smoking cessation Ves 4(5) 3(5) 0.937
plan if applIcable No 59(95) 88(95)
Diel counseling Ves 101(88.5) 98(72) <0.001 t
No 13(11.5) 38(28)
Exercise counseling Ves 91(80) 92(88) <0.030 t
No 23(20) 44(32)
• Chl·square statistical significance If p < 0.05
t Chi-square statistical significance In favor of the before group
"
4.2.3 Predictors of risk factor rnanagerntnt
Logistic regression analyses were ~eted to determine whether 1) age (S 70
yrs YS. >70 yrs). 2) sex Of 3) location (Central Health Region (CHR) YS. non CHR)
were predictive of effective management strategies including: measurement of
lipids. treatment with lipid lowering therapy (LLT) at discharge. ~etion of the
\'NO CV risk fadar forms and cofT1)letion of the cardiac education form. Although
many variables could have been Included In these analyses, these three were
induded, particularly to assess any age or gender bias, which has been
discussed extensively in the literature. Also. since the GHHSC is the primary
referral center. location was selected to determine if geographic location could
affect risk factor identification documentation and management.
The only variable reaching a level of statistical significance was that of age in
relation to completion of the two CV risk factor forms. If age was :>0 70 years it
was predictive of non-completion of the t'NO CV risk factor forms (p < 0.001). (see
data appendix K)
4.3 Results pertaining to phase II;
Of the total 52 survey questionnaires distributed to cardiology staff in October
2000, the initial response rate was 35% (0=18). Following mail out of reminder
letters there was an additional 10% (n=5) return. With the remaining initiatives
from November 2000 through Janu.-y 2001, inc:luding placement of reminder
signs on the cardiology floor. making survey packages avaJabte at the January
nurses' staff meeting and personal reminders to four cardiologists, the final resutt
was COfT1)Jetion of 41 of 52 survey questionnaires (79% response rate) (See
table 4.5).
Table 4.5: Cardiology staff survey questionnaire response rate by specially:
# survey
questionnaires
disbibuted
II completed survey Response
questionnaires returned rate (%)
Cardiologists 8
Nurses
Dietitian
Total
43
52
33
41
88%
77%
100%
79%
Survey questions addressing the perceptions of cardiology staff in terms of roles
and responsibilities included:
1) Who, of the following health professionals, do you think should be involVed
in risk factor identification and documentation during the hospitalization
period?
S7
2) Who. of the following health csro ,,-_/0, do you think should be
in_in a riM factor mon-, $/1atagy (including aducalion)
during tho AMI hospitalizalion pariod?
In both questions. respondents almost unanimously agreed (40 of 41
respondents or 98%) that all of the stated hearth professionals including
cardiologists. nurses and dieticians should be involved in the identification.
documentation and management of risk factors. (see table 4.6) ResUts are
reported in aggregate to maintain anonynity.
Table 4.6 Cardiology staff perceptions 01 roles and I8SpOf\slbilities for in-hosplta
CV risk factor identification. documentation and management
AU respqndents 'DIW!f!d the followlna' B!ul!I!HI;
Who should be Involved in CV risk factor Frequency ......nl
identific.Uon & documen,.tIon7 -,
Cardiologist 0 0%
Nu... 1 2%
Dietician 0 0%
All 40 98%
Who should be Involved CV risk factor
m.nagement?
Cardiok>gist 1 2%
Nu... 0 0%
Dietician 0 0%
All 40 98%
"
Other findings of interest:
Despite the fact that all survey respondents had at least three months
experience on the cardiology floor, it was determined that the levet of
awareness for the December 1998 implementation of a cardiovascular risk
factor management strategy was low. More than one third (37%) of
respondents were not famiUar with the standing order to measure lipid
profiles in the CCU. Forty·two percent were not familiar with the cv Risk
Factor Profie Form; 46% were not familiar with the CV Risk Factor
Management Form and 27% were not famillar with the Cardiac Education
Fom>. (see table 4.7)
Table 4.7 Awareness of CV risk factor management strategy induding lipid
profile measure in CCU (CCU order) and three chart forms
Awareness Frequency Percent
of: n=41
CCU order Ve. 25 61%
No 15 37%
Unsure 1 2%
CV risk factor Ve. 24 58%
profile form No 17 42%
Unsure 0 0%
CV risk factor Ve. 22 54%
management No 19 46%
form Unsure 0 0%
Cardiac Ve. 29 71%
education No 11 27%
form Unsure 1 2%
"
• Survey responses pertaining to the frequency of adequate cardiovascular
risk management in the current time period (faU 2000) are reported. Only
22% of respondents said risk factor management was adequate all of the
time or most of the time (all of the time 2%, most of the time 20%); the
majority of respondents, 76%, answered some of the time (see figure 4.1).
(0=41)
80"'{'
60%
40%
20%
0%
All of the time Most 01 the Some 01 the Rarely
time time
Figure 4. 1: Staff peroeptions. frequency of adequate risk factor management
According to 100% of respondents, risk assessment and education should
begin before the day of discharge (either in CCU or post CCU but before
the day of discharge). However. 51% of respondents report that risk factor
assessment and education actually takes place on the day of discharge
(see figure 4.2).
60
(0=41)
80%
60% .RIF management should
40% .RIF~aetual
20%
0%
Figure 4.2: Cardiology staff feedback on when in·hospital risk factor assessment
and education should begin v.s. when it actually begins.
Despite the low level of awareness for the stJalegy itself. forty-six percent
of respondents agree that the December 1998 risk factor management
strategy has improved the status of risk factor identification,
documentation and management at the GHHSC.
Summary of additional comments included on survey questionnaires by
respondents:
Of the thirty-three nurses who completed survey questionnaires, in
thirteen cases there were unsoficited comments referring to the need for a
full time cardiac teaching nurse for 5SA. Reference was consistently made
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to the lack of available time to dedicate to the ifT1)Oftant responsibility of
risk factor management and education. Several conments referred to the
current situation as being -unfair to patients.. It was also said that,
"without someone assigned speci1icaIJy to that duty, it will not get done..
Ten respondents incfuded physiotherapists as an allied health
professional with a potential role In risk factor management. in particular
for "teaching and establishing an exercise regime.. The social 'NOrker and
pharmacist each received one mention 8$ potential participants for overall
risk. factor management planning.
The slaff dietician was noted specifically on one questionnaire as the
person Mseeing patients routinely for counseling before the day of
discharge"
The cardiovascular risk. fador forms are not being seen by cardiologists in
aU cases.
There was one remark with the perception that the dietician and nurses
were doing all they could do to manage risk fadors, but Cardiologists, as a
group, were not
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There appears to be -uneven application ofcardiac teaching and
completion of ri$k factor forms, /i(eIy in relation to human resource
.va"'blily~
Ongoing updating/education of staff nurses regarding issues relating to
cardiovascular risk factor management would be appreciated.
• Improvements seen in cholesterol management may be -due to recent
publications and new guidelines".
The need for -continuiy of care ofrisk factors post-hospitaJ discharge
needs to be addressed. Although ifI.hospital education is very important it
should not stop there. Some follow up wlh cardiac rehab and or the family
physician is neede(r.
4.4 Summary of resutts:
The statistical findings of phase I address the objectives of the before/after
comparisons of chart reviews. Specifically the analyses indicate that the
December 1998 in-hospital CV risk fader management strategy was partially
effective to improve identification, doaJmentation and management of risk
facto<s.
.,
Phase II of this study demonstrates darity or consensus among cardiology staff
members that a team approach, induding can:iologists, nurses and dieticians is
desirable for in-hospital CV risk factor identification, documentation and
management. Taking that consensus and moving it forward so that it becomes
practice is the challenge for the Mure.
..
CHAPT/;R 5
DISCUSSION
"
5.0 Review
The purpose of this study was to examine the etrec:t of an in-hospltaf
cardiovascular risk factor management strategy in high-risk p3St-AMI patients at
the GHHSC and to assess the pen::eptions of cardiofogy slaff members in tenns
of roles and responsibilities for cardiovascular risk factor identification,
documentation and management.
Review of the literature dearly identified management of cardiovascular risk
factors as a key component of Pf8\'8ntive care. In the high-risk secondary
prevention post AMI population, reduction of cardiovascular risk factors has been
proven to reduce morbtdity and mortality (5.7.9.41,42).
The literature identifies the ongotng problem of achteving cardiovascular risk
reduction in the real Yt'Orid situation (18.19). Although reasons for this lack of
success are likely multifactorial. it has been suggested that the aoote
hospitalization period, such as post-AMI. represents an opportunity to begin a
long-term ptan for cardiovascular risk reduction in a high-risk population. this is a
challenge requiring a well p1aMed and implemented strategy (16,17,21.67.79).
The cardiovascular risk management strategy implemented at the GHHSC in
December 1998 was an atte~t to intervene in the high-risk AMI population.
Within the strategy. process changes were implemented to streamline and
66
enhance risK factor identification. doaJmentation and management for post AMI
patients. This study sought to determine the effectiveness of the strategy.
The following drscussion will focus on topics from the methods section and the
results section of this paper.
5.1 Methods discussion
5.1.1 Oeye!ooment and initiation of the 1M strategy
Phase I of this research compared the identification, documentation and
management of risk factors in the before and after groups. The results
demonstrated partial success in terms of improvement in the after group.
Following is a discussion of possibfe methodological reasons for the limited
success of the 1998 strategy.
The original planning committee for the 1998 strategy induded a cardiologist. an
endocrinologist, two nurses and a dietician from the cardiology division, thus
representation from each discipline involved. However, co-ordinated group
planning meetings were nOl routinely held. Despite the fact that surveyed staff
members had more than three months experience on the cardiology br, it was
evident from the survey results that many staff members were not familiar with
the strategy or were familiar with only part of it (27%. 46% of respondents said
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they were not aware of aspects of the strategy, see tabfe 4.8). This Jack of
awareness may have had a negative impact on the i~tationof the
strategy.
Specificaay, tor the three new chart forms implemented within the risk
management strategy (CV risk factor profie form, CV risk factor management
form and catdiac education fonn), the rate of utilization (completed forms on
charts) was very low at only 27%,27% and 62% respectively. Possi~ reasons
for this low level of utilization include:
a) Lack of awareness or commitment to the use of the forms or the strategy itself.
b) Lack of some process to fadNtate ease of form utilization. The nurses or the
dietician were required to go to a specific filing cabinet to obtain forms and add to
the patient chart, they were not routinely included as part of the chart that is
prepared in advance by the ward dert.
c) Early in the period after the forms were impfemented, it was noted that the first
two forms required a tick off of risk factor(s) ·only if present", raising the question,
if a tick was absent, was it by design or omission? Also, staff members realized
that significant time was being spent completing forms, 'Nhich, to their
knowledge, were not being seen by the cardiologists or resutting in follow up after
discharge. Suggestions for i~vementswere made and forms revisions began
within six months of iff4)lementation. Therefore, the enthusiasm for the original
forms may have dininished. Lastly, during planning for the original strategy, the
..
need for a transition letter i:) patients' family physidMS desaibing their risk
profiles had been discussed. This also did not happen, perhaps once again
da~ning enthusiasm for the avera. strategy and negatively affecting its
potential success.
It is possible that the results of the overall strategy muld haw been very different
if full implementation of the dlart fofms had occurred. Perhaps a more
collaborative, ground up approach, which sought to gain input from all cardiology
staff members for the strategy d8\l8k)pment and implementation, would have
resulted in increased utilization of forms and thus the strategy.
When used, the new chart fofms facilitated a more ~hensiveoverview of
patients' risk management planning and the specifics of teaching, including
resources used. Previously, for example, the education or teaching documented
in the chart was minimal, often evidenced as a simple statement that cardiac
teaching was done. The forms, when used, resutted in enhanced quality of
documented information.
5.1.2. Chart abstraction
Through the months of August to December of 2000, the researcher abstracted
all study charts in the medical records department. By chance. the first 100
charts reviewed 'N8f8 from the after group. Once review of charts from the before
..
group began it became clear that the Cardiac education form available on the
Matler" chal"ts was not included in the Mbefore" charts; this was another new form.
Originally. the researcher had been infcrmed of only two chart forms involved in
the December 1998 risk management strategy. Following investigation with the
cardiology nursing staff. it was confirmed that. indeed. this third chart form was
i"1Jlemented at the same time as the CV risk factor profile form and the CV risk
factor management form. Therefore. upon request by the thesis supervisor and
investigator. medical records staff retrieved the first 100 charts from Ihe after
group to identify whether the education form was utilized. This infonnation was
necessary to obtain utilization rates for this newly identified form.
Had the review of "before" charts been COI1lMeted first. there'M)Uld have been no
need to retrieve the 100 "after" charts for a second review.
5.2 Results discussion
5.2.1 In-hospjtal mortality
The irrhospital mortality reported for the GHHSC. the tertiary care center for the
province. was 18% in the before group and 13% in the after group. These rates
are similar to the AMI mortality rate reported in the ICONS population. which
indUdes AMI patients entering any ICONS affiliated hospital within the province
of Nova Scotia. whether It is a community hospital or the tertiary care center. The
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ICONS aggregate AMI In-hospital mortality rate reported in the spring of 2000
was 14.4% (31).
A 1996 study, Myocardial Infarcbon Patients in the 1990s - Their Risk Factors,
stratJrlCBtion and Survival in Canada: The Canadian Assessment ofMyocardial
Infarction (CAMI) Study, reauited 4,133 AMI patients in nine hospitals (eight
university and one community-based) In Canada. The GHHSC was one of the
sites in the CAMl study. Patients IIWre identified by reviewing all daily hospital
admissions to the CCU or ICU as well as through routine questioning (three
times per week) of cardiologists on call in order 10 access any off service AMI
patients within the hospital. Finally. all emergency room deaths were reviewed
and patients meeting study criteria for AMI were included in the study.
For patients of all ages recruited to CAMl after November 1, 1991, the in-hospitar
mortality rate was 9.9%. This rate is loNer than the 18% (before group) and 13%
(after group) rates reported in the current research. In younger CAMI patients
who were less than or equal to 75 years (93% of the population). the in-hospital
mortality rate was 8.4%. The in-hospital mortality rate for the older groups was
higher (>70 years to 75 years was 15.8 % and > 75 years was 27.6%) (68).
The reported in-hospital mortality rates of 18% and 13% for the before and after
groups respectively in the current research initially seem high when ~red to
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9.9% for all patients in CAMI. When one considers the demographics of the
current study population (25% ,. 70 ~ars in the before group and 42% ,. 70
years in the after group versus 23% ,. 70 years in the CAMI popufation), it could
be that the increased representation of elderly patients in this resewd1 has
contributed to the higher rrortality rates. However, that seems unWkely with the
highest percentage (42%) of elderly patients included in the after group Vt'ith the
lower, 13% in-.hospttal mortality rate.
Pemaps of more i~nce when considering possible reasons for the rrortality
differences, the CAMI study had strict recn.atment procedures and criteria to
determine AMI eligibility. The current research involved simple tdentiflcation of an
ICD 9 code 410 from an administrative database. The populations identified
through two such differing processes were likely very different, making
comparisons less than optimal.
5.2.2 N0rH:!ocumentation of risk factors
The patient chart is the ultimate source of information and communication (72).
Without documentation of particular risk factors such as sm:lking and
hyperlipidemia it is intOOive, although not yet proven. that there will be less
management of them.
Findings of the current research in terms of non-documentation of risk factors are
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similar to the findings of the ICONS project. ~mentation of diabetes
status was 24% in ICONS versus 22% and 25% (before versus after groups
respectively in the current research), cholesterol status non-documentation was
27% in ICONS versus 27% and 22% in the current research and non-
documentation of smoking status was 6% in tCONS versus 13% and 12% in the
current........ch (23).
As eartyas 1995 the issue of non-documentation, although not tenned as such,
was being investigated by a group of Canadian researchers, the Clinical Quality
J"l'rovement Network (COIN). Their study, Low InciderJce ofA$sessment and
Modification ofRisk Factors in Acute ea,. Patients at High Risk for
Cardiovascular Events, Particularly Among Fern8les and the Elderly (71),
detailed the patterns ofassessment and treatment of serum lipids and other
modifiable risk factors in 3.304 hospitalized high--risk patients for cardiovascular
events in four acute care Canadian hospitals. The investigators found the most
preval:ent documented risk factor was hypertension (46%). Diabetes, obesity,
smoking, dystipidemia and positive famity history were reported in 21 % • 28% of
patients. Sedentary lifestyle was documented in only 3% of patients. Similarty,
there was a low rate of lipid assessment (28% overall) and dOOJmented
management of lipids and lifestyle risk factors was kJoN.
Based on the low level of recorded risk assessment and management, the COIN
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investigators hypothesized that more risk assessment and management was
being performed than was actually being recorded on the patient c:h.-t. A
substudy COf1l)8ring reo:Jf'ded risk assessment and management with data
obtained directly from patienlS before discharge was performed in 117 high--risk
patients. Substudy results found that there was $ight underreporting of the
assessment of smoking status and sedentary lifesIyIe. but there were no
differences between patients' records and their responses 10 questions pertaining
to assessment of hyperlipidemia or for being prescribed lipid lowering diet and/or
drug therapies. The medical record therefore appeared accurate as a true
reflection of cardiovascular risk assessment and management in the acute care
setting. Although an accurate reflection, it was dear that the level of risk
assessment and management was low. The COIN investigators conduded that
there appeared 10 be a widespread gap in the application of dinicallrial and
epideniological knowledge regarding risk-lowering measures in this high-risk
population. They challenged cardioJogislS to find ways 10 improve practice and
outcomes in one of the most i~rtant diseases in society. Three years later. in
initiatives such as the December 1998 GHHSC risk management strategy, thai
challenge is being addressed.
Recent advances toward the establishment of electronic patient records could be
one solution to improving the assessment and documentation of risk factors. In
1999, researchers in Illinois investigating the impact of electronic patient records
on practice found that this method significanlly increased the documentation of
assessment for decision making and more appropriate documented decision
making as judged by an expert panel (72). It cot.id be argued that an etectronk:
patient record system that prompts for appropriate documentation would offer
solutions to numerous aspects of patient care including the issue of chart non-
documentation of cardkwascular risk factors and subsequent management.
5.2.3 Cooparison of before/after risk factor identification and documentation
Only one of seven variables sefeded to determine cardiovascular risk factors,
history of previous CAD, was statlsticalty significanlly increased in the after group
versus the before group. Documentation of previous MI and cholesterol status
showed a positive trend (perhaps if the sample size was larger they would have
reached a level of statistical significance); otherwise, variables 'Nl!re largely
unchanged (see table 4.3). The intervention can be considered only partially
successful in improving identification and documentation of cardiovascular risk
factors. It must be noted, h0'N8ver, that the implementation of the intervention
itself was only partiaJ (27%, 27% and 62% utilization of the CV risk factor profile,
CV risk factor management and Cardiac education form respectively), which
likely had a negative impact on the results.
5.2.4 Conparison of befpre!after risk fidor management
Of the eight variables selected to detennine risk factor management, four were
"
significanay improved in the after group versus before. A greater number of
patients had their lipid profiles measured, were started on Npid lowering
medications before discharge, received stress counse4ing and srT'Il)king cessation
counseling (see table 4.4). Documented requests for foItow up of lipids or
smoking cessation were unchanged. Surprisingly there were significant changes
seen in the before group in tenns of diet and exercise counseling. Overall, in
terms of the strategy, there was a greater improvement reported (four of eight
variables with p < 0.001 for each) for management of risk factors than for the
identification and documentation of risk factors (one of seven variables with
p < 0.04). Thei~nt in lipid management can likely be attributed to the
routine order for lipid measurement within 24 hOln of adnission to CCU as we"
as to temporat changes ocwrring with increased awareness of publications and
guidelines supportive of lipid management in high-risk patients. The dimate in
the year 1999-2000 was more conducive to irHlospitallipid management than
was the case during the baseline measurement of this research in 1997-1998.
It remains puzzling that diel and exercise counseling results 'N8r8 better in the
before group. It could be that human resource issues, such as staff shortages,
contributed to this result, or it could someho¥I relate to the implementation of the
new chart forms. Possibly staff members who did not use the additional chart
fonns left it for another to do. In the surveys it was evident that the dietician was
noted as playing a major role in co~etion of the forms. Perhaps staff began to
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see it as her rote alone. Whether the cifference is in the 8ClUal1eYeI of cot.meIing
given. or its documIntItion. remains undear.
5.2.5 Timing of lipid !!!IIN!!lW!t post AM!
AJ. the time of the a.wrent resean::h there was~ debate as to~
lip;d profiles should be .._ in post AMI patients. The aaJte phase
response phenomenon, which occurs usually after the 24-48 hour post-event
period. tends to lower total and LDl choIesten:Jlleve!s (46), which could H!ad to
Inappropriate reporting of normal levels in those with etevated levels sustained
over the long term. Therefore. it is irJ1)Ortant that if measured in-hospital. the lipid
profile should be obtainod oatty (within 24 hours at the GHHSC).
Large diniall OiaIs such as 4S and CARE studies (41.42) have demonstraled
mortality and mo<bidity benefits in AMI pa__ with stalin drugs post
event, but those trials initiated therapy three to six months after the event. " is
recogniZed that this delay in treatment has likely resutted in missed opporIu1ities
to intervene in this high-risk population. Very recenly however. the CHAMP
study (79) and the _ish Registry study (67) reported rno<1BliIy benefils at one
year in high risk patients trealed with a statin before or at the time of hospital
discharge versus those not treated. These new data support the opportunistic top
down, in-hospital approach for ~pid management as discussed in this paper. The
in-hospila initiation of stltin treabnenl post AMI is more widely accepted
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currently in 2001 than was the case during the time of this research. To optirrize
the benefits obtained with stalin drugs post AMI. somo cordicloglSlS wm initiate
thefapy irH1ospita/ with a plan III docraase or cisa>ntinue. Wnecessary. at tho
time of foAow.yp. The obvious key 10 whic:heYer strMegy is S8MJdtd is pfaming
and foflow-up.
5.2.6 &my guestionnoiCQ mAs
Results of tho cardiology staff "'My quostionnairM suggest that staff mo.-s
view cardiovascWar risk factor identification. documentation and management as
an essenu. part of patient care in the acute care setting. There is consensus
0lI'00ll staff monWn that all have a role 10 play in acIlilMng .. appropriate _
of risk factor identification. documentation and management. The rn:>st common
reason given for lack: of attention to risk factors dOOng hospitalization by survey
respondents (nurses onty) was lade of time. The recommended solution (also by
nurses) was 10 hire a full time nurse educator vmo 'MJUkf be responsible for risk
factor management Such a position would answer the ll'M'l8diate short term
resource issue. but over the long term. the challenge would be to aeate a
collaborative team approach 10 risk factor assessment and management as was
suggested from staff survey 1'8SlAts. The goal shoUd be a strategy thai begins in
hospital and extends beyond the acute C'M8 setting to Ihe primary care physidan
for long-teon follow-up and management.
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nwoold have been~_ng Ill ......__....-..Iength of
experience on the caf'(jQggy ftoor influenced Il.I'VeY responses. HoweYer. due to
the small numbers involved and the need to rreinlain conftdentlality, this was not
feasible in the current research. Anecdotally, the majority of 8dditionaI conments
that were received. espedaIIy in the case of the nurses. C8fM' from those with
more than tour years experience.
5.3 Unitations of the Study
The study has been restricted by certain conditions that were beyond the
resean:::her's control. These data were gathered from. two and one half
year tirre period. The short time period examined likely will not be
representative of the sibJation in some releSting period.
Curing this time period, a resttuduring of cardiology seNices OCCtKl'ed that
resulted in more cardiologists being involved in care of patients at the
GHHSC. During 1997-1998 there were four cardiok)gists responsible for
patient ewe in the ceu and on the can:iology unit, whereas during 1999-
2000 there W8A! six to eight cardiologists. Therefore, charts reviewed In
the atler time period captured a new mix of practice patterns induding
these additional physicians, lNhich could account for some of the
difforenc:e$.
19
The sbJdy has also been restricted in terms of the voluntary nature of the
safT1)ling of cardiology staff for the survey questionnaire portion, There
may be a bias in terms of who responded to the survey questionnaire and
it is possible that the ideas of individuals choosing not to participate differ
significanUy from those Vt'ho COf11HIed survey. However, with a near 80%
response rate (missing only one of eight cardiologist and 10 of 43 mKSes)
these results likely retied the opinions of the majority.
• Information pertaining to in--hospital management of risk factors obtained
in this study came solely from chart reviews. It may be that risk factor
education and management planning were discussed and/or
implemented, but not documented. That would result in an over estimate
of the problem of sub-optimal risk factor management. However. non·
documentation is a component of the problem being investigated.
The scope of the study has been limited to hospitalized, AMI patients.
Therefore, results of this study may not be descriptive of other, similar,
although not acute populations such as community patients with CAD.
The study has been restricted to one hospital site within the Heatth Care
Corporation in 5t. John's. Findings cannot be considered representative of
some other hospital in 5t John's or other geographic locations.
..
CHAPTER'
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6.0 I~icationsand condusions
The following chapter Mil discuss possible i~icatlons of the current research
findings and conclusions.
6.1 Implications of current research
6.1.1 Further development of the strategy
Emerging evidence supports the aaJte hospitalization period as an appropriate
starting point for cardiovascular risk factor management (67.79). Several positive
opportunities exist for future cardiovascular risk factor management at the
GHHSC. The tested strategy for this research should be considered a pi40t
project where issues and opportunities were fdentified to facilitate future
improvements. Perhaps the fact that there was only partial implementation of the
strategy resuUed in the limited improvements seen in the identification.
documentation and management of cardiovascular risk factors.
Currently, the chart forms are being revised and a part time teaching nurse
position has been added on the cardiology Door. The challenge will be to further
develop and I~ement the in-hospital risk reduction strategy ensuring input and
collaboration of all staff. The addition of further resources such as aitical path
algorithms, to prompt staff through patient care as reoommended by guidelines,
could enhance the success of the strategy as well (50,79). There is currently an
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oppoftunity to utilize the added nursing position to further develop the current
strategy and perhaps take it a step further by linking It to comroonlty primary care
physidans. This nursing position has the potential to do much more than one on
one patient education. Considering the aJf1'8f1t low level of awareness for the
strategy among staff members, there is surely a need to re4aunch the new and
Improved strategy in some collaborative way.
6.1.2 Chart nOfHlocumentation
This research has added to the emerging literature pertaining to lack of chart
documentation. This problem affects not only Individual patients, but also raises
concems about research based on chart reviews where data are abstracted for
various epidemiological studies including calculation of rates. Without a true
pict:Jre of which patients actually have a oondition, i.e. diabetes, the numerators
and denominators for these studies will be inaccurate. It Is incorrect to assume
that if something is not dOOJmented it is not present. Further research is
required to quantify the situation and find ways to correct the problem. As
previously mentioned, chart forms that are deveWped and implemented in a
collaborative way (29) and/or the evolution of electronic patient records (36) offer
potential solutions, which require evaluation.
IJ
6.1.3 ContInuous qualjty impr0y8ment
Continuous quality improvement is an essential COO'1>Onent of health care;
ongoing feedback of quality incicalors such as those examined in this research
assist with quality assurance. A yearly review and feedback of findings from a
S8fT'C)le of AMI patienlS to examine cardiovascular risk factor identification,
documentation and management, and perhaps utifization rates of evidence--
based therapies induding ASA, beta blockers, statins and angiotensin converting
enzyme inhibitors, coWd be completed with minimal resources. Such a practice
would add grealty to quality assurance efforts for the dMsion of cardiology at the
GHHSC.
6.1.4 Post AMI patient tducation
Although efforts are focused on education of patients post-AMI ip.hospital, it is
undear whether patients comprehend and retain information received in the
acute care setting over the long term. Opportunities exist now, although limited in
terms of availability for all, for early outpatient education through the cardiac
rehabilitation program or in cotlaboration with primary care. Future research
could examine post-AMI patients who have recetved different types of education
Interventions with differenl timings, to assess over the long term which strategies
work best to change behaviors and/or ifT'C)r0Y8 patient heatIh outcomes.
..
6.1.5 Further irnprpyer!!tnt in rpid management
This research identified inaeased measurement of lipid profiles with the addition
of the CCU routine standing order to do so. It also.identified 29 documented
cases where reported lipid VlMue5 were above recornrnended levels and patients
were discharged home without treatment It may be that later follow up was
planned and not documented on the chart or it may be that these were missed
opportunities to intervene >Mth high-risk patients. Examples of success in similar
situations have been reported in the CHAMP study with the use of a6g0rithms
(50,79) and in the UK with nurses empowered to prompt physicians to treat when
levels exceeded reconwnended values (30). Such initiatives could be tested or
i~ementedat the GHHSC to improve treatment of lipids when appropriate.
6.2 Condusions
Cardiovascular disease is one of the most deadly diseases worldwide; in Canada
it is the leading cause of death. Due to significant research initiatives over the
past t\'YO to three decades many advances in knowtedge of prevention and
treatment of cardiovascular disease have been elucidated. The future challenge
is to not only continue the pursuit of new and innovative $1rat8gje$ to improve
prevention, treatments and health outcomes. but also to ensure implementation
of the numerous strategies already proven beneficial.
"
The current cardiovascular risk reduction strategy examined within this paper
was only partlatly effective In improving identification. documentation and
management of cardiovascular risk factors.I~ts likety were seen, in
part, due to the strategy examined herein; otherwise the new mix of cardiologists
deliVering care in the after time period or the temponll trend ofi~ng lipid
management in the hospital setting may have been contributors to the changes
seen in the after popufation.
Given the current situation at the GHHSC with a) agreement among cardiology
staff that all have a role to play in risk management in·hospttaI. b) the addition of
a staff nurse position for patient leaching and c) the planned feedback of findings
from this research. the future holds promise for an improved risk management
strategy.
Ongoing anatysis of the risk reduction strategy is necessary to measure its
effectiveness. Research evaluating the bridging of cardiovascular risk reduction
from the acute hospitalization period to community primary care physicians is an
exciting new challenge.
Improvements in the process of care dEKivery should lead to improvements in
patient hearth outcomes. The CHAMP data and the Swedish registry data
support this hypothesis. As numerous heatth care cenlers and personnel invest
..
time and resources to optirrize processes of care. ongoing monitoring and
research are essential to test these strategies and measure their effectiveness.
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Ifyes.tq)laiD' _
PrevioulMI:
Positive Family History VetO, NoD, NIDO
Known devaled Cholesterol: YesD, NoD, NIDO
Up'ds ......red wltbia 3 mos. prior to MI
Or Upids measured ill hospital: VesD, Noel NIDO
htiea. on Lipid Iowen•• therapy oa adlaissfo. Yes 0. No 0 NJA 0
Iryes.,espllila _
VesD. Noel NIDO
earreat Smoker: Yes 0. NoO,NIDO
'08
VaD, NoD. NIDO
VaD, NoD. NIDO
Hypeneasio.:
IT yes" OD trfttIH.t :
Ifya.erpWD _
Diabetes:
IT Dlaktie, OD trntmeDt :
[rplala
VaD, NoD, NJDO
YaD. NoD, NJDD N/AD
Lipid profile ordeml ucordlq to ""'-C ecu order:Yn D, No 0 No ftAlk 0
If ..... aDy erpla.atioD :
Are two risk factor Iorms complete:
Is NuniaC form ~mpltle:
Are risk faeton doeumeated elsewbere 0. mart:
YaD. NoD
YnD, NoD
YnD, NoD
Ifyn.,wbere:
Physkia.s Dote D
Nunesaote D
Dletkia.s Dote 0
Otber D
ErplliD, _
Action / pll! bued on rilk 'IdOt idutirKil!tIon:
PIID to meuure Uplds I. Dtllr future:
Smokinc eessation effort in hospUaI:
'09
VnD, NOD,N/AD
YnD, NoD, NID ON/A D
Ync\' NoD, NlDo, N/A 0
BJP It disehlrge _
OllbetltS Managed in boIpltal:
RIeL Supr o. Idmlssi.. _
Bid. Sapr It cUKblfge _
In hospital Urcstylt disc1ISJion re:
YelD, NoD, NID14NJAO
YcsD, NoD, NIDD, NfA 0
YelD, NoD, NIDO
YetD, NoD, NJDO
YcsD, NoD. NJDD
Did:
Rywhom:
Pbysklln 0
Nurse 0
Dittidl. 001.... 0' _
Stress:
Bywbom:
Physicil. 0
Nurse 0
Oletld... 0
Other 0'- _
Enn:isc:
By whom:
Physicil. 0
Nurse 0
Dlttlcll. 0
Otb... 0, _
Is there I plan ror Upid follow lip: YesD, No 0. NJD D,NfA 0
Is there I plan ror smokinl cessation rollow up: Yes D, No 0. NID D, NJA 0
Is chere planned rollow up with Primlry are pbysicl..: Yes 0. No 0. NID 0
SpeclaJisC: YesD,NoD, NIDO
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o
o
o
o explain _
c-.pktiM Dldla f.atiDtllUIi.~dtDfl1ll tIIU IIbmtt j.ltJ _milia. AU """"'Mis fin
~ AU ctJMpkud f.aliDlllMins ctUf be kft ill,.e.~IiIbdd IlIJK
ASSESSMENToues"QNNA/lIES ill Mtlrk Drtf/nt'$ D/fb Off 5$A D' die EKG
Dqt or die Clltlt LIlA TlrtlJfk ytHIlOI'YD'" J""Iicipfttnt.
I. What is your position within the cardiology division at the Health Sciences
Center?
Cardiologist
N.".
Dietician
01....
2. Please indicate length oftime you have worked in Cardiology at the Health Science
Center (Hsq.
Less than six months 0
Six months to less than one year 0
One to two years 0
Three to four years 0
Five to ten years 0
More tban ten years 0
3. Were you working in Cardiology at the HSC before the implementation of the CV
Risic management strategy in Dec. 1998?
y" 0
No 0
4. Do you perform any in-hospital post MI risk faclor management! teaching?
If Yes., is it:
Fonnal (dedicated time for discussion) 0
Informal (general interaction, ie. bedside conversation) 0
E:tplain' _
III
s. Are you l3.miliar with the standing ecu admission order to measure &sting lipid
profiles in acute Ml palients that was implemented in Dec. 19981
Yes 0
No 0
Notsure 0
6. Are you aware ofthe risk factor form titled, CV Risk Fadar ProfUe that was
imp~memedin Dec. 19981 (see attachment #1)
Yes 0
No 0
Notsure 0
1. Are you aware oftbe risk factor form titled, Risk radar Ma.apawnt Plan that was
implemented in Dec.I9981 (see anachment #2)
Yes 0
No 0
Not SW'e 0
8. Are you aware oCtile education from titled. Cardiac EdtK:lltioo Fona that was
implemented in Dec. 19981 (see attachment #3)
Yes 0
No 0
Not sure 0
9. How often do you feel patients are receiving adequate education regarding risk factor
reduction while in hospital?
All ofthe time 0
Most of the time 0
Some of tile lime 0
Rarely 0
Never 0
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10. Who. ofllle following health care professionals, do you think shoukl be involved in
risk factor hleDtiflcI:tleD ud docu-.eDtadoD during the bospitalization period?
(please cbeck an chac apply)
Cardiologm 0
Nurse 0
Dict:ician 0
Other _~o~==============:.Please explain_
II. Who. ofdle following heakh care professionals. do you chink should be involved in a
ri9: factor IUDaaelDnlt strategy (including education) dwing the MI hospitalization
p<riod?
Cardiologist 0
Nurse 0
Dietician 0
Other _~o:================-Please explain_
12. When, in the post MI period. do you think risk assessment I education should begin?
InCCU 0
Early post CCU to day before d~charge 0
Dayofdischatge 0
Othe< 0
P\easeexplain
13. From your observation, when does r~k assessment I education for these patients
usually occur?
[nCCU 0
Early post CCU to day before discharge 0
Day ofdischarge 0
~~eXPlain 0, _
"'
14. in Dec.I998 a standing ordcr for lipid profile mcasurcmmtwas implemented inCCU
and risk assessment/education ronns were introduced to SSA? Do you think risk
identificalmll. documentation and management bas improved for acute MI paricltts
since that time?
y~ 0
~ 0
Unsu<e 0
N/A(oot working on floor prior to Jan 1999) 0
Plcaseexplain
IS. Do you think the standard CCU order for lipid profile in MI patients tbat was
implemented in Dec. 1998 bas resulted in: (check all that apply)
Improved documentation of lipid risks Yes O. No O. Unsure 0
Increased measurement of lipid levels Yes O. No O. Unsure 0
Improved education pertaining to lipid management Yes O. No O. Unsure 0
Improved treatmentofelcvated lipid levels Yes O. No O. UIlStft 0
16. Do you think the two Risk. factor forms that were implemented in Dec. 1998 have
resulted in: (check all that apply)
hr.,rovedassessment ofcardiac risk factors Yes O. No 0, Unsure 0
hnproved documentation ofcardiac risk factors Yes O. No O. Unsure 0
Increased edUcalaoR pertaining 10 cardiac risk filclors Yes O. No D. Unsure 0
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17. Do you think: the Cardiac Education Form that was implemented in Dec. 1998 has
resuhed in: (check all that apply)
Improved assessment ofcardiac risk factors Yes 0. No 0. Unsure 0
Improved documentation ofcardiac risk factors Yes 0. No O. Unsure 0
Increased education pertaining to cardiac risk metors Yes O. No 0, Unsure 0
18. Do you have any additional comments pertaining to the assessment I management of
cardiac risk factors in the Post Ml patients:
TlratytnI for J1DIIrJHlrtidpfItUm in tlti, raevcII project.
B".lIkS.CocJrrtllf~
Please make sure to complete the attached yellow card and take it and the
completed questionnaire to oae of the three drop off locations (Marie Duffett's
office on SSA or EKG or the catb lab).
,I>
13 Westminster Or.
MtPc:arI,NOd.
AIN4M9
""""""000
(-_OJ
I am currently completing a Master ofScience (Community Health I Epidemiology) at Memorial
University ofNew£oundJand The title of my thesis is: B_ altratltlY Ie Improve risk
eneullleOt.1MI ........ poll Ame M)'cte:ardlal ......rdIo. aI IH Bahb ScieKel
CeDler beu IDCCmfat?
My study involves a chart .udil ofpariems discharged with a primary diagnosis of AculeMI. The
audit wiU include chans of patients discbarged ODe year before. IIDd after December 1998 when a
risk f.ctor assessment I management strategy was implemented.t the Health Sciences Center,
division of cardiology.
Inpul from cantiologists. nurstS and dieticians working with acute MI paticm is essc:ntial to my
analysis of the current situation as well as formulating recommendations for future management I
am therefore asking for your assistance.
I have enclosed a survey questionnaire, which should take about 5·10 minutes to complete. Once
completed, please <k'op it in the box labeled Rjd: Assessment Ouqtionnaires in Marie Duffett's
office on SSA or the EKG department or the cath lab. Participation in this study is entirely
voluntuy and confidentiality is ensured - no names will appear on any survey forms. In order to
allow follow up of non-returned surveys, I am also enclosing a ~conf"umation ofsW'Vey
completion card". This card is to be dropped in the separate envelope labeled Conf1DT@tionCards
found next to the box for qucsliollJ'-lircs.
I anticipate c~letion of my thesis in early 2001. I will be happy to share my findings a1 that
time, either formally Of informally.
Thank you for your assistance.
Sincerely,
BoMie S. Cochrane
MSc.Student
Memorial University of Newfoundland
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(ApponcIIx F)
Confinnation ofsurvey
Questionnaire completion.
Slgnature: _
rffia,,/,-8/our,-.~
Bonnie s. Cochnl".
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13 Westminster Dr.
Mt. PearL Nfld.
Aln4M9
November 2000
I am currently COlq)lcting a Master ofScience (Community HealtblEpidemiology) at
Memorial University ofNewfowxIland. The: title of my thesis is: Has a strateeY to
Impreve risk auetlmeat aad .....aee-e-t pelt Acute Myoca.rdiallBfardiea at tile
BeaJtII Sdatces Ccater ben ,ftCft,r.r.
(n October you sboukl have m:eived a survey questionnaire, which will assist my
analyses by giving important insight iDto staffperspectives on eatdiovascularrisk
management. in tbe bospitalized MI patient. To dale I have oot m:eived your completed
=vey.
Input from cardiologists, nurses and dieticians working with acute MI pIrients is CSSCDtial
to my analysis oftbe curreoI situation as well as tom.dating recommeDdations for future
management. I am therefore asking for your assistance. Please accept this as a reminder
to complete the survey. Ifyou dkl oot receive one, or have misplaced the original, there
arc: extns located in Sharon Meehan's office on 5SA
Thank you for your assistance.
Sincerely,
Bonnie S. Cochrane
MS<. Student
Memorial University ofNcwfoUDdIand.
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(",-""Ix K)
~ K.1 Data utilized ",Iogislicregr-. ",-.nne~ ofrisl<
_~indu<Ing: ipid_wi1hin l'24ho<nof_
or pnMous _ rnonlhs (ipid rnoasur8), _ of ipid lowering -.py at
discharge (LLT 01 dischorgo), 0l>lTClI0Ii0n 01_ <::II risk_forms (21otms
~)ond ~oI__ Iorm(EdUClltionIorm~).
Patients included in the~ are those in the -8ft8r group" "=136
......-
LlTatcllctwge 2Fcwmsc::cmplltll -.
-
--
na87/138(lU%} n=42/136(31") na37/138(27%) 841136(42%)
V.. v.. v.. v..
'Ill) ""I ""I <>1"1
51. 55(83) 20(117) 32(11) 52(62)
>70 32(37) 4(33) 5(14) 32(38)
T.... 87(100) ~100) 37(100) 84(100)
-
60(69) 29(69) 30(81) 57(")F_ 27(31) 13(31) 7(18) 27(32)
T.... 87(100) 42(100) 37(100) 84(100)
CHR 60(78) 32(78) 29(711) M(7lI)
Non-<:HR 21(24} 10(24) 0(22) 18(21)
T.... 8'7£1(0) 421'(0) 371100) 84f100l
Appendix K.2 Results of Iogislic rogrossion onolysos 10< pnldidors 01 <::II risk
management in the after group ("-136)v_
......--
OnLLTat ~d2 ~d
""-'" """- cv"'-.
--
........3_
p"''' pV.1Je P"'''' Pyalue
""" .....
'.935 0.210 ....... 0.281
-
'.930 0.810 0.175 0....
""""""
0.... 0.732 0.428 0.583
·StatiltiCal~lIp<O.05
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